ArticleVaccines2025

Engineering and Evaluation of a Live-Attenuated Vaccine Candidate with Enhanced Type 1 Fimbriae Expression to Optimize Protection Against

Patricia García et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.